OR WAIT 15 SECS
January 18, 2021
How engaging with digital influencers holds the key for medical affairs.
December 18, 2020
If the life sciences sector can support healthcare professionals to gain confidence in substituting original treatments with new biosimilars, prices will reduce and patient outcomes will be enhanced.
November 11, 2020
Implementing an efficient means of unifying disparate data and allowing teams to utilize this single source of truth data will allow them to track KPIs more effectively and get key insights when they need them.
October 14, 2020
A look at best-practice approaches to aligning the strategy and design of hub service models with preparations for market entry of a new therapy.
Tips for rounding out the rough edges in crossover.
October 13, 2020
Female medical affairs leaders speak out with unique perspectives on how MSLs can provide greater value to opinion leaders.
September 30, 2020
Assessing the landscape of the pharma industry’s readiness for future pandemics by looking at past pandemics, funding and revenue, and sustainability.
September 29, 2020
Addressing the challenges faced by Global Medical Affairs teams and how they can find balance to create maximum value for their organizations.
In this article, Eli Lilly & Co. examines risk management in the context of partnerships with other companies.
September 20, 2020
Dr. George Westerman talks to Michael Wong about how smarter executives will successfully lead their workforces in a post COVID-19 business environment.
September 14, 2020
Beyond necessity and nice-to-have, embracing real-world evidence as a true strategic differentiator.
While COVID-19 has shifted some of the rules, research reveals that practice changes were already afoot for market newcomers.
Uncovering fish oil derivative’s benefit for heart health.
New hope accompanies overdue recognition in sickle cell disease fight.
The world’s most expensive drug put in context.
September 11, 2020
How adoption of the key account management (KAM) model can help drive pharma’s agility in reaching and influencing a more diverse set of healthcare customers and decision-makers.
Amid pandemic, rely on the fundamentals.
September 08, 2020
Looking at four building blocks of success, Wolfram Lux and Simone Seiter investigate what it takes to win and be successful when commercializing an orphan drug
August 31, 2020
A look at how pharmaceutical company, Paratek is navigating the launch of a new antibiotic during the COVID-19 pandemic.
August 19, 2020
While HCPs are turning away from in-person meetings with sales reps amidst the COVID-19 pandemic, there are still strategies for them to keep their pipelines full.
